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• We study the impact of changes to a stroke pathway following a simulation study.
• We evaluate quantitative system performance and critique the modelling process.
• Patient treatment rates increased fourfold while arrival to treatment times halved.
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• VIS proved more useful for initial engagement and project buy-in.
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a b s t r a c t
Very few discrete-event simulation studies follow up on recommendations with evaluation of whether
modelled benefits have been realised and the extent to which modelling contributed to any change. This
paper evaluates changes made to the emergency stroke care pathway at a UK hospital informed by a
simulation modelling study. The aims of the study were to increase the proportion of people with strokes
that undergo a time-sensitive treatment to breakdown a blood clot within the brain and decrease the
time to treatment. Evaluation involved analysis of stroke treatment pre- and post-implementation, as
well as a comparison of how the research team believed the intervention would aid implementation
compared towhat actually happened. Two years after the care pathwaywas changed, treatment rates had
increased in line with expectations and the hospital was treating four times as many patients than before
the intervention in half the time. There is evidence that the modelling process aided implementation,
but not always in line with expectations of the research team. Despite user involvement throughout the
study it proved difficult to involve a representative group of clinical stakeholders in conceptual modelling
and this affected model credibility. The research team also found batch experimentation more useful
than visual interactive simulation to structure debate and decision making. In particular, simple charts
of results focused debates on the clinical effectiveness of drugs — an emergent barrier to change. Visual
interactive simulation proved more useful for engaging different hospitals and initiating new projects.
© 2015 The Authors. Published by Elsevier Ltd.
This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
This paper describes the implementation and evaluation of
changes to an emergency stroke care pathway in a large acute
hospital within the United Kingdom. These changes followed a
discrete-event simulation (DES) study thatwas undertaken to both
identify improvement opportunities and support the implemen-
tation of improvement between the clinical stakeholders in the
pathway. The aim of the intervention was to increase the
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a time sensitive treatment to break down a blood clot within an
artery in the brain (thrombolysis with the drug alteplase). The
full technical details of the simulation model are published else-
where [1]. The purpose of this paper is to evaluate the impact of
the study in improving the real-world system. We define impact
in three ways: did the results of themodel influence decisionmak-
ing in the context of the problem; did the changes implemented
improve real world performance as defined in the project; and did
the modelling intervention/process influence the chances of im-
plementation as the research team expected. The evaluation of im-
pact was conducted using a two-stagemethodology: an analysis of
data pre and post implementation and a comparison of how the
le under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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tion compared to what actually happened.
The DES literature contains many case studies of computer
models that compare alternative policies to identify costs and
efficiency savings within industry [2] and healthcare [3]. While
these case studies are numerous the evidence that such modelling
leads to the implementation of simulation results is lacking.
Although not exclusively limited to a particular domain, this lack of
implementation evidence has been particularly well documented
in systematic reviews within healthcare DES modelling [3–7].
Notably, over the period of 12 years spanning the publication
of these reviews only a small number of studies describing the
implementation of simulation results in healthcare have been
published (e.g. [8,9]).
Evaluations of implementation processes are increasingly
conducted in other areas of health services research such as health
technology assessment [10] and health program evaluation [11],
but are rare in Operational Research (OR). A plausible reason
for the apparent lack of implementation accounts and follow up
evaluation is the tension between the time needed to implement
change within an organisation and the timescale for publication
of model results; although it is arguable that such a tension is not
unique to DES and OR. One reason that may be specific to OR is the
tension between what is seen as legitimate research and what is
consultancy [12]. Academics in OR gain little reward for publishing
relatively standardmodels using text bookmethodology, although
implementing results of such models may be of great help to
organisations. On the other hand, evaluation research is valuable to
the academic community, particularly in the context of increasing
recognition of the need to value the positive impact of research
in society. Not only does evaluation demonstrate effectiveness or
issues with use of methods, but it at its core challenges researchers
to revisit and test their assumptions about how they expect a
modelling intervention to work [13]. A larger evidence base in
the area of evaluation should lead to improved methodology for
conducting modelling interventions using methods such as DES.
The contributions of this study are therefore threefold: evidence
that the results of healthcare DES modelling interventions are
implemented in practice; quantitative evidence that changes
recommended by DES can lead to real system improvement
and improved stroke patient outcomes; and revised propositions
about how simulation modelling interventions aid the changes of
implementation.
The paper begins with the background to the simulation study
including an overview of the model, expected performance, the
changes implemented, and how the research team believed the
intervention would work. We then present the results of a quan-
titative evaluation confirming that the hospital has seen sub-
stantial improvement following the study. This is followed by a
qualitative comparison of how the research team believed the
intervention would support implementation compared to what
actually happened. The final section draws together the qual-
itative and quantitative aspects of the evaluation and assesses
the accuracy of how the research team believed the interven-
tion would work. Final comments discuss the need for system-
atic research into the implementation of results from similar
projects.
2. Background to the simulation study
2.1. Thrombolysis for acute ischaemic stroke
Ischaemic events account for over 80% of all cases of stroke [14].
The only licensed treatment for acute ischaemic stroke is throm-
bolysis with alteplase, a treatment intended to restore blood flowwithin an artery occluded by thrombus (blood clot). Due to the
highmetabolic demands of brain tissue, the effectiveness of throm-
bolysis is critically time dependent [15,16]. The earlier a patient
receives treatment the greater the chances of recovery with mini-
mal or no disability, such that the effectiveness of the treatment
halves with each 90 min period that passes from onset [17]. As
with all drug treatments there are also risks. In this case treat-
ment increases the risk of symptomatic intracranial haemorrhage
(SIH: bleeding within the brain), that often leads to death. How-
ever, when treatment is given within 6 h of onset, the accumu-
lated evidence shows that the benefit of stroke thrombolysis in
reducing disability outweighs the risk of intracranial haemor-
rhage [16,18].
In Europe, alteplase was originally licensed in 2003 for use
within a three hour period from the onset of ischaemic stroke. In
that time the patient needs to travel to hospital and be assessed
and treated in an emergency department (ED), including brain
imaging. Uptake of the treatment has been slow, often because of
difficultieswith completing the diagnostic processwithin the short
time window, with between 3.5% and 5% of patients receiving the
treatment [19]. Efforts to increase this proportion have focused
on two areas: randomised controlled trials (RCTs) assessing the
efficacy of extending alteplase treatment from three to four and a
half hours (or beyond); and public education campaigns to increase
awareness of stroke symptoms (e.g. the act FAST campaign in the
UK) in order to encourage earlier presentation to hospital with
suspected stroke. The benefit of thrombolysis is measured in terms
of the increase in the proportion of patients with minimal or no
disability at follow-up (usually 90 days), attributed a modified
Rankin Scale (mRS) score of 0 or 1. The mRS is an ordinal scale of
disability scoring between 0 (no symptoms or disabilities) and 6
(death; [20,21]).
2.2. The modelling intervention
Similar to many other hospitals in the UK and elsewhere our
hospital treated 4%–5% of all acute strokes annually with alteplase,
with the majority of treatment delivered close to the three-hour
treatment deadline. The project reported here was initiated in
late 2010 as a collaboration between hospital clinicians and med-
ical school academics to investigate the most effective operational
changes that could be made to increase thrombolysis rates and re-
duce stroke-related disability. We chose to use DES to model the
stroke pathway as we believed it represented a compromise be-
tween the expert and facilitativemodes of engagementwith stake-
holders [22] that others have described as pseudo-facilitative [23].
We chose this approach based on three core beliefs. First, we be-
lieved that in order to achieve any agreement on change within
the hospital we needed to operate in the facilitative mode of en-
gagement during conceptual modelling [24]; aiding the relevance,
transparency and credibility of results to the stakeholders’ prob-
lem. Second, DES provides the opportunity to use visual interac-
tive simulation (VIS). We believed that VIS would increase the
engagement of stakeholders, enabling validation and experimen-
tation, thereby improving the transparency of the model, both of
which are prerequisites for effective implementation [25]. Third,
we believed that modelling in general would provide a com-
mon reference point and structure debate between stakehold-
ers with competing interests. These three hypotheses represent
how the research team expected the modelling intervention to
support the implementation of the results of the DES study. The
final section of this paper reflects on these hypotheses and evalu-
ates if these assumptions were indeed the key factors that aided
implementation.
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The DES model focuses on the emergency phase of the stroke
pathway. Other modelling studies of stroke care and discussions
of their potential benefits have been published [26–33], but none
provide any details of implementation or health impact. For brevity
this section provides a high level description of the model. More
detail on model inputs and logic pathways can be found in the
online supplementary material (see Appendix A); details to fully
replicate the model can be found elsewhere [1].
2.3.1. Model logic
The model is divided into four sections: a pre-hospital phase,
an ED phase, a referral phase, and a phase where the acute stroke
team (AST) takes responsibility for the patient. The main problem
identified at the project hospitalwas that inmany cases the referral
phase was delayed. That is, patients with suspected stroke arriving
at the hospital were subject to the common delays in triage and
assessment experienced in busy EDs and became ineligible for
the time sensitive treatment. A key component of the process is
emergency brain imaging with a CT scan (during the AST phase).
This is used to rule out brain haemorrhage as the cause of stroke.
Two key components of the in-hospital delay to assessment and
treatment that were simulated were the time from arrival to CT
scan (ATS) and from scan to treatment. A full pathway diagram is
included in the online supplementary material (see Appendix A).
2.3.2. Outputs
The model was used to explore the impact of different
configurations of the stroke pathway in terms of thrombolysis
rates, time to treatment, urgent clinical workload and ultimately
patient disability at 90 days. Disability measures were represented
as the number of additional patients with a 90-day mRS of 0–1
attributable to treatment (as some patients will recover without
treatment).
2.3.3. Experimental factors
The main experimental factors were the paramedic pre-
alert rate (where paramedics phone ahead alerting clinicians to
the imminent arrival of a patient with suspected stroke), ED
triage referral rate (where triage nurses contact the AST as they
encounter patients with suspected stroke), the time window and
the likelihood of further contra-indications to treatment, most
notably intracerebral haemorrhage. The inclusion of paramedic
pre-alerts and early referral at triage were chosen as they provide
the earliest possible points for emergency referral to the AST.
Paramedic pre-alerts, in most instances, allow for a specialist
stroke nurse practitioner to meet patients with suspected stroke
at the doors of the ED. The inclusion of contra-indications was not
a practical implementation aspect to explore, but it is an important
parameter to help quantify the uncertainty in our model outputs.
2.3.4. Summary of model results
Model results were presented to the clinical stakeholders
using a standard pairwise comparison approach for scenarios [34],
particularly making use of graphical plots to communicate
differences. Here we focus on the uncertainty in the model results.
To illustrate the results of the model we include a 23 factorial
design including two of the early referral parameters and the
proportion of exclusions between midnight and 11 am (due to
our concern about underestimating the proportion of ‘wake-up’
strokes where the onset time is unknown). Full results, main
and interaction effects are provided in the online supplementary
material (see Appendix A).The range of uncertainty for the overall thrombolysis rate was
predicted to be between 7.9% and 14.2% of patients. More impor-
tantly, the results demonstrated the critical importance of high
compliance with the referral protocol by paramedics and at ED
triage. Low compliance in one while the other is high was ex-
pected to reduce the proportion treated by 1.1% (95% CI 1.0%–1.3%).
As such, the study recommended that the hospital and the local
ambulance service implement robust protocols for pre-alerts both
pre-hospital and within ED.
2.4. Implementation of results
The development of the model and its use took place over six
months (January–June 2011). Implementation took place over the
following year and was led by the AST with support provided
by a simulation modeller. The project timeline is illustrated by
Fig. 1. Implementation of the results of the study was phased:
from December 2011 (phase 1) stroke patients were referred from
ED triage directly to the AST, and from August 2012 (phase 2)
paramedics began phoning the AST to alert themprior to suspected
stroke arrivals in the ED. In addition to the recommendations of
the DES study the hospital also extended the alteplase protocol
to treat patients over the age of 80 from May 2012 following the
publication of a large randomised controlled trial [35].1
3. Quantitative evaluation
We follow the overview of the simulation study with a
quantitative evaluation comparing stroke thrombolysis pre and
post-implementation. The post-implementation data cover a
period of 21months. This section summarises the study design (the
full protocol can be found in the supplementary and presents the
results (see Appendix A).
3.1. Study design
Four treatment variables are evaluated using a pre-intervention
post-intervention design: the time taken from a patient arriving
at hospital to brain scanning (ATS), the time taken from arrival
to treatment (ATT), the thrombolysis rate (the number of patients
receiving thrombolysis as a proportion of the total number
of strokes in the time period) and the number of adverse
events including SIH. We also measured compliance with the
early referral protocols. Data were collected prospectively from
01/01/11 until 31/08/13. Statistical tests are described in the online
supplementary material (see Appendix A).
3.2. Results
3.2.1. Participants
Detailed thrombolysis data were available from 2007 until
September 2013. We limited the analysis of thrombolysis rates
in the pre-implementation period to between 01/01/09 and
30/11/11, as absolute numbers of thrombolysed patients were
notably lower prior to 2009. The post-implementation period
ranged from 01/12/11 until 31/08/13. In total this provided 2930
cases of stroke (1851 pre and 1088 post-implementation). Fig. 2
illustrates this breakdown in more detail.
3.2.2. Main results
The total proportion of strokes thrombolysed pre-imple-
mentation was 4.7% compared to 11.5% post-implementation.
1 Diamonds represent important project milestones.
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Summary of main outcomes.
Pre Post
Arrival to scan times
N 100 107
Mean (SD) 58 (30) 33 (20)
Median (IQR) 51 (37) 27 (26)
10th Percentile 25 12
90th Percentile 107 63
Arrival to treatment times
N 93 106
Mean (SD) 90 (35) 63 (26)
Median (IQR) 85 (46) 58 (35)
10th Percentile 51 36
90th Percentile 145 102
Thrombolysis rate
All stroke cases 1851 1088
Thrombolysed cases 87 (4.7%) 125 (11.5%)
Thrombolysed cases excluding over 80s and inpatients 73 (3.9%) 75 (6.9%)After exclusion of the over 80s and in-patient strokes these figures
fall to 3.8% and 6.9%, respectively; giving an absolute increase in
thrombolysis rates of 3.1% (95% CI 1.3%–4.7%). Average ATS fell
by 24.7 min (95% CI 17.5–31.8) with overall average ATT falling
by a similar amount (26.3 min; 95% CI 17.7–35.1). A substantial
impact of the change occurs in the tail of the distributionwhere the
90th percentile was reduced from 145.0 min (95% CI 126.4–164.0)
to 102.9 min (95% CI 91.1–115.0) a difference of 42.1 min (95%
CI 18.0–68.1). There were four adverse events in 2011 of which
three were SIH (7%) and six adverse events post-implementationof which three were SIH (3%). Table 1 summarises these main
outcomes.
3.2.3. Subgroup analyses
Before the modelling study took place average ATT appeared
to be increasing. Average ATT was notably higher in 2010/11
(101 min; 95% CI 90.1–111.2) compared to period preceding 2010
(76 min; 95% CI 67.7–83.5); skewing improvement estimates. We
therefore conducted a subgroup analysis limiting analysis of ATT
to patients treated between 01/01/2010 and 31/08/2013; giving a
44 T. Monks et al. / Operations Research for Health Care 6 (2015) 40–49Fig. 3. Thrombolysis rate by half yearly interval.difference in average treatment speed of 37min (95% CI 25.7–48.9)
following implementation.
Fig. 3 illustrates the thrombolysis rate by half yearly interval
starting frommid-2007 (July to September 2013not shown).When
results are limited to phase 2 of implementation (from August
2012) the hospital achieves its highest thrombolysis rates: 14.5%
overall, 11.0% excluding patients over 80. ATT times continued to
fall in this time period reaching an average of 55.5 min (95% CI
46.5–64.5); a reduction of nearly 50% compared to 2010/11.
3.2.4. Adherence to paramedic stroke referral protocol
A total of 671 patients with a diagnosis of stroke were admitted
after phase 2 implementation; 504 of these arrived by ambulance.
Cases of suspected stroke are identified by ambulance paramedics
using the Face, Arms, Speech and Time (FAST) test. Given that
average FAST diagnostic sensitivity has a 95% confidence interval
of 76%–85% [36], we estimate that between 383 and 433 of these
patients would be identified by paramedics en route to hospital
(assuming that a diagnostic test was applied in all cases).
A total of 201 pre-alerts were received post phase 2. Using the
estimated FAST positive numbers we converted this figure into
an average adherence to the pre-alert protocol of 46% (201/433)
to 52% (201/383). These figures are skewed by the gradual
effect of dissemination in the months following the protocol
implementation. If all 2012 data are excluded, adherence rises to
63%–71%.
4. Qualitative evaluation
Drawing on our knowledge of the involvement hypothesis in
the DES and SystemDynamics (SD) literature [37] and experiential
knowledge from clinical practice, we developed three hypotheses
that reflected our belief in the importance of adopting a facilitative
approach and involving clients in modelling.
Hypothesis one draws from the PartiSim (Participative Simu-
lation) framework for healthcare simulation [24]. Involvement of
clients from different parts of the system in conceptual modelling
is reported to increase the credibility of results as objectives and
themodelling process are clearer to clients. Althoughwe ranwork-
shops involving a group of stakeholders in conceptual modelling,
we chose not to adopt the full Soft SystemsMethodology (SSM) ap-
proach advocated in the PartiSim framework in favour of simpler
brainstorming and process mapping exercises.
Hypothesis two reflects one of the core rationales for VIS. If
system behaviour is communicated to clients as a model runs,either for validation or experimentation, then this is proposed to
facilitate trust in the model and results and hence increases the
changes that results are implemented [25,38].
The final hypothesis is based on reported benefits of engaging
clients in facilitative modelling [22]. Although often associated
with problem structuring methods, for example SSM [39] or
Strategic Options Decision Analysis [40], facilitative approaches
have been shown to be feasible in DES studies [38,41,42], for
example SimLean facilitate [42], and Group Model Building in
SD [43]. The process of developing a model is often argued
to foster the development of a common language or point of
reference for stakeholders that improves the quality of debates
about action [44].
Stated concisely, our three hypotheses were:
• If stakeholders are involved in conceptual modelling then
the relevance, transparency and credibility of results to
stakeholders are increased.
• If stakeholders can be engaged by VIS in validation and
experimentation then the resulting model transparency of
working relationships increase the use of results.
• If stakeholders with competing interests are engaged in
a modelling project then debate about implementation is
structured by the model acting as a common reference point.
This section provides a qualitative evaluation of implementation
by comparing these hypotheses to what actually happened
in the intervention. Data collection was through the lead
modeller’s field notes (TM). In instances where the modeller
was leading a meeting, for example when validating the model,
conversation was recorded and field notes were made afterwards.
In more sensitive meetings, i.e. those discussing implementation,
conversations were not recorded and notes were made from
memory immediately following the meeting.
4.1. Hypothesis one: user involvement in conceptual modelling
The acute stroke team (AST), which is comprised of stroke
physicians and specialist nurse practitioners, approached the
medical school to initiate the intervention and were subsequently
heavily involved throughout the study. We also believed that
conceptual modelling should involve the ED, as a substantial part
of the emergency pathway (and controllable processes) occurred
there. We did not involve the ambulance service in conceptual
modelling at the outset, but provided themwith provisional results
once available.
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We engaged the clinical lead of the ED at project initiation,
as it was felt that he would represent the views of the wider
group of consultants in ED. The preliminary project meeting took
place in October 2010 and was used to define clear performance
measures and scenarios from the outset. In attendance were a
modeller from the medical school, the clinical lead of the ED
and the stroke physician who would act as the project liaison
between the medical school and the hospital. The ED clinical lead
was involved in making two key contributions to the conceptual
model: key performance measures would include the proportion
of strokes treated and treatment speed from arrival at the hospital;
while scenarios should compare the impact of early referral after
triage to that of extending the licensed window for thrombolysis
from 3 to 4.5 h after onset. The meeting ended with an agreement
that the AST would lead the project and report the results of the
modelling back to the ED.
4.1.2. Involving the AST
The AST added further model outputs and experimental factors
to the conceptual model in the early part of 2011. There were
two new key performance measures to include: the increase in
prioritised scans (to assess workload changes) and the number
of patients with minimal or no disability at 90 days due to
treatment. The lead AST clinician felt that the latter measure was
less abstract than time to treatment andwould be important when
communicating the results to the wider clinician audience and
the ambulance service. The AST, particularly the specialist nurse
practitioners, were also involved in process mapping and model
validationworkshops. This prompted a further experimental factor
to be added to the model: the rate at which paramedics’ pre-alert
the AST to imminent stroke arrivals.
Implementation of a pre-alert systemwas thought to be plausi-
ble, as ambulance crews already provided pre-alerts to the ED for
other emergency conditions. A potential barrier to implementation
was thought to be a change of control in the pathway; i.e. a move
from the ED to the AST. A plausible solution was to design an in-
formation chain: where the ambulance crews pre-alert the ED and
then the ED passes the information to the AST. Although some in-
formation would risk being lost in such a system, it was believed
that the wider group of ED consultants were more likely to agree
to implementation on these terms. There was also some concern
that prioritised brain scanning might lead to many false positives,
typically identified by an ED consultant, consuming resources that
would be better served elsewhere. As such, the scenarios were de-
signed to include specialist assessment by an AST nurse prior to
brain scanning.
4.1.3. Influence on implementation
The modelling was completed in six months with results
reported to the AST and ambulance service shortly afterwards.
Although engaged at a relatively late stage, the reaction from the
ambulance service was supportive, observing that it was quite
rare to get any feedback on what they as paramedics can do to
influence patient outcomes. They stated that the outputs from the
model allowed them to see what disability impacts might be if
they pushed for high pre-alert rates for all FAST test positive cases
of suspected stroke—an area where it is typically very difficult
to make any difference. Interest was such that the ambulance
service were keen to work more closely with the medical school
to investigate factors during ambulance callout, pickup and travel
that might help increase treatment rates further.
While we were able to quickly disseminate the results to the
AST and ambulance service, we were unable to organise a meeting
with the ED until five months after the modelling was completed.The meeting included all consultants from the ED (including the
clinical lead) and was led by the AST with the medical school
providing support regarding the modelling.
The initial reaction of a subgroup of ED consultants to the mod-
elling results was negative. Discussion of the model assumptions
revealed that this group had concerns about the evidence base for
thrombolysis and had further concern about the increased propor-
tion of patients suffering SIH leading to higher mortality rates—a
measure that was not modelled explicitly (our mRS 0–1 measure
implicitly incorporates those patients suffering SIH and going on
to have good functional outcome). This was a surprising reaction,
given our previous experiencewith the ED clinical lead and that the
most up to date evidence clearly supported the opposite view on
the value of thrombolysis [15]. It was apparent that the emergency
medicine literature took adifferent position on acute stroke throm-
bolysis to the neurology literature. In particular, the re-analysis of
an early RCT by an opponent of thrombolysis argued that therewas
no evidence of a time dependent benefit [45], although this work
was subsequently disputed [46].
Our conceptual model, therefore, was missing a key output
measure: the proportion of patients suffering early SIH due
to treatment. We did however have a simple model of SIH
available: we expect that 4%–7% of treated patients will suffer this
complication [18]. We had not included this in the model as there
was no evidence that SIH was related to onset to treatment times.
Nonetheless, this exclusion affected study credibility among the ED
clinicians.
With regard to the control of the pathway and screening of false
positives before brain scanning, the reaction was more positive.
The consensus from the ED clinicians was that implementation
would work more smoothly if pre-alerts went directly to the
AST. This was due to the high number of pre-alerts the ED
already received for a variety of emergencies, and recognition that
reducing the information chain meant a more robust solution. Our
design for screening for false positives by AST prior to any brain
scanningwas also acceptable to the ED consultants, recognising the
specialist knowledge of the AST specialist nurses.
The outcome of the meeting was positive and swift. The ED
clinical lead contacted the AST the following week (December
2011) and confirmed that the ED would go ahead with a change
in the pathway. In summary, we found that involvement of
stakeholders in conceptual modelling did help with the relevance
of findings leading to implementation; however, selection bias
meant that stakeholders did not represent the full range of views
on change.
4.2. Hypothesis two: VIS
We primarily used VIS during model development between
March and June 2011. Although this was originally planned to
facilitate both validation and experimentation it was mainly used
by the lead modeller for the former. Much of the discussion was
therefore of benefit to the modeller rather than the stakeholders
and does not support the original assumption. For example, a
specialist nurse would be shown a simulated patient arriving at
different times of the day to illustrate how the model passed
information about the patient between clinical groups. The nurse
would then help clarify the order of information exchange.
In contrast to VIS the batch run results provoked more
lively responses from stakeholders and prompted discussions of
implementation. Aswe have already reported, both the ambulance
service and ED were responsive to simple charts illustrating
the differences in system performance across scenarios (for very
different reasons).
We also used VIS after project completion (July 2011 onwards)
to illustrate the simulation approach to other hospitals. As the
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regional stroke network the medical school was approached by
four further trusts (three hospitals and the ambulance service)
with interest in implementing similar simulation projects within
their trust. We met with each of these trusts and visually
demonstrated the model and scenario comparison. In these cases
the use of VIS achieved more engagement and discussion of
possible implementation options at the trust. Between December
2011 and January 2013, simulation modelling was conducted
with two of these trusts while, due to data availability, statistical
analysis and visualisation of patient pathways were used with the
remaining two.
4.3. Hypothesis three: a common reference point
The clearest example of debate about change was in the final
project meeting between the ED clinicians and the AST lead. Both
parties had the patient’s interest at heart yet both took radically
different views on how to manage emergency stroke patients.
Here the model results both for treatment rates and patient
disabilitywere themost useful. Although some consultants reacted
negatively to the proposals, their objections used themodel results
as a common reference point in their arguments; for example,
‘‘are those disability results real in the pre-alert scenario’’. This
prompted a discussion of the clinical assumptions included within
the model and provided a forum for clinicians with concerns to air
their views. This evidence agreeswith our initial assumption about
the model acting as a common reference point.
The exact influence of this imposed structure on the success
of implementation is difficult to discern from a single case study.
However, we propose that the process of setting up a meeting
with ED and presenting quantified resultsmay have helped change
clinicians’ attitudes. Some evidence of this can be seen in the
comments from two ED clinicians towards the end of the meeting.
In particular, they appreciated the time taken to perform the
analysis and meet with them for a discussion as opposed to ‘the
usual approach of specialities e-mailing a demand’. In other words
the more collaborative nature of our engagement within their
organisation persuaded them to positively consider the changes.
5. Discussion
This paper makes two contributions to the DES and OR
literature. Firstly, evidence of the effectiveness of simulation in
improving health systems is provided through our evaluation
of the impact of implementing the results of a DES study in
emergency stroke care. Secondly, we compare the research team’s
assumptions about how the intervention was supposed to work
to what actually happened to assist planning of OR projects to
maximise influence and impact. We report these contributions in
this section as follows. Initially we summarise the utility of the
simulation by comparing the actual outcomes of implementation
to those predicted. Then we critique the three assumptions
regarding the use of modelling and implementation set out in
the introduction. We close the section with a discussion of the
strengths and limitations of our evaluation.
5.1. Model utility and validity
Our results clearly demonstrate that improvement occurred in
the hospital’s management of emergency stroke patients over the
timescale of the project. More stroke patients are treated in shorter
periods of time, particularly after phase 2 of implementationwhere
the new thrombolysis rate represents a threefold increase in the
number of treated stroke patients under the age of 80. These
improvements, falling into the middle of the range predicted byourmodel, are substantially higher than other recent thrombolysis
improvement initiatives [47,48]. We also observed a gradual
growth in the proportion of patients treated as opposed to a step
change, due to a dissemination effect where paramedic pre-alerting
rose gradually from around 25%–30% in the latter part of 2012 to
60%–70% in 2013.
Although we had no over 80s population to compare to pre-
implementationwe know that these patientswill also benefit from
the more responsive process post-implementation. As average
treatment time approximately halvedwe can also expect thatmore
over 80s patients are treated than would have been. Our model
predicted that treatment of the over 80s would increase from 7 to
31 patients per year using the paramedic pre-alert system.
We used a conservative approach to confirm improvement by
including the period in which the simulation study was conducted
within the pre-implementation period. It is noteworthy that the
thrombolysis rate observed pre-implementation is skewed by
the period in which the simulation study was conducted. Our
explanation of the during effect relates to the nature of the change.
Implementation relates not only to hospital protocols, but also
the relationships that the specialist stroke nurses have with their
colleagues in ED and radiology. Anecdotally they reported an
improvement in these relationships through their participation in
the study. This in effect means that the triage referral system was
implemented, to some extent, before the official sign off in the ED.
The utility of the model was affected by our decision not to
incorporate the incidence of SIH resulting from thrombolysis. This
decision was made with user involvement, although this figure
turned out to be influential with the ED clinicians not involved
in the study. As expected the actual incidence of SIH pre and
post implementation was similar and within expected limits from
the evidence base [18]. In terms of the validity of our model, the
decision not to explicitly incorporate SIH as an outcome measure
is legitimate; however, it did cause credibility issues with a group
of ED clinicians and serves as a clear reminder of the difference
between validity and credibility [49].
5.2. Did the simulation study work as expected?
To effectively evaluate a modelling intervention the underlying
assumptions about how the intervention was supposed to work
must be surfaced [13]. Table 2 summarises the three assumptions
outlined in the introduction to the research against evaluation
findings and several propositions refined on the basis of the
evaluation.
Our first hypothesis was that involvement of stakeholders
in conceptual modelling aids the relevance, transparency and
credibility of results and hence chances of implementation. We
involved representatives from both the ED and AST at the
beginning of the study. However, the views expressed by the ED
clinical lead were not fully representative of the larger clinical
group, a finding which surfaced substantially later in the project.
Therefore we neglected to include a key output (risk of SIH)
in our model. The impact of this decision on model credibility
demonstrates that involvement in conceptual modelling can
indeed be a critical component of implementation. We note,
however, that in practice the stakeholder group involved in
conceptual modelling has to be limited in size; hence it is difficult
to judge the representativeness of the wider stakeholders. Our
experience at the other hospitals, where ED was more extensively
involved throughout, also suggests that selection bias is in play.
The representatives from ED who wished to be involved in the
project were those with the most positive views towards the
treatment. Although selection bias in the main project group will
be difficult to eliminate entirely it is likely that members of the
project group will be aware to some extent of colleague’s views.
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Hypotheses about the modelling process, findings and post-evaluation propositions.
Hypotheses Findings Post-evaluation propositions
1. If stakeholders are involved in conceptual
modelling (CM) then the relevance, transparency and
credibility of results to stakeholders are increased.
1.1 ED were involved in CM right at the beginning;
however, it proved difficult to involve a representative
group of clinicians
• If stakeholders who are representative of the
wider organisation are involved in CM then the
relevance, transparency and credibility of results
to stakeholders are increased.
1.2 Individual ED clinicians not involved in CM were
critical of the evidence base for thrombolysis, but once
involved in discussion of results were able to reach a
consensus that changes should be implemented
• If stakeholders who have not been involved in
CM are later involved in discussion of results
then their focus on process improvement can be
developed or reinforced.
1.3 The ambulance service was not involved in CM,
but were keen to implement results
2. If stakeholders can be engaged by VIS in
validation and experimentation then the resulting
model transparency and development of working
relationships increase the use of results.
2.1 Little evidence that VIS increased engagement
within the project; more useful for validation of model
logic.
• If stakeholders are unfamiliar with modelling
then using VIS in validation and experimentation
improves initial engagement and buy-in; but to
improve the use of model outputs (in a clinical
setting) requires the presentation of results in a
more conventional scientific form.
2.2 VIS effective for demonstrating the model to
other hospitals and securing new project work
3. If stakeholders with competing interests are
engaged in a modelling project then debate about
implementation is structured by the model acting as a
common reference point.
3.1 The model’s clinical assumptions and results
were used as a common reference point to debate
post-treatment disability.
• If a common forum for the mutual exchange of
information and experiential knowledge can be
developed then the uptake and integration of
different forms of knowledge are increased.
3.2 ED clinicians were more willing to consider the
results due given the manner in which the study was
conductedA simple approach within OR interventions, therefore, is interview
stakeholders individually and ask what social or political factors
affect performance improvement. This approach is similar to initial
stages of SSM, i.e. investigating the social norms and roles within
an organisation. This line of questioning may also help identify
key individuals whose views are not currently represented by the
project group and that could be invited to join.
In contrast to the ED and AST, the ambulance service was
not involved at all during conceptual modelling or the larger
intervention. However, results were welcomed with enthusiasm.
A possible explanation of this is that ambulance services are
highly focused on continual improvements in responsiveness. The
changes recommendedby the study reinforced these organisational
objectives and the manner in which the ambulance trust
conceptualised problems. Therefore, although involvement in
conceptual modelling was not essential in this case, inclusion of
the ambulance trust in discussion of resultswas essential. In the ED
several senior clinicians were more focused on the medicine than
process. Involvement of these individuals in debate around results
was also essential as it provided an opportunity to develop their
focus on process improvement. This latter hypothesis also provides
a practical workaround for the selection bias issue for the main
stakeholder group involved right throughout an intervention.
Our second hypothesis concerned the use of VIS to increase
stakeholder engagement. We found little evidence of this within
the project. In fact many clinical stakeholders were more
interested in the batch run results presented using simple charts.
The main use of VIS, therefore, was as part of model validation,
i.e. stepping through model logic with the AST. A possible
explanation is that the presentation of results in medical science,
i.e. tables of summary statistics and measures of accuracy, is more
akin to batch run results in simulation than process animations.
Themore ‘scientific’ appearance of these results in this contextwas
therefore more engaging for clinicians.
Unexpectedly, the model was much more engaging to stake-
holders outside of the project. VIS was particularly helpful in en-
gaging clinicians and managers from elsewhere who heard about
the work through the local NHS Stroke Network and were keen
to replicate it at their hospitals. This less-tangible aspect of dis-
semination, if not implementation, is perhaps overlooked when
discussing the impacts of a simulation study. Thus we propose
an alternative formulation of our original hypothesis about VIS: ifstakeholders are unfamiliar withmodelling then using VIS in valida-
tion and experimentation improves initial engagement or buy-in to
simulation. Further researchmay wish to consider if these types of
effects are specific to modelling techniques that lend themselves
to animation or if this is a more general benefit across modelling.
Our third hypothesis concerns using a model to provide
stakeholders with a common reference point to debate change,
an idea that is well documented within OR. In our study the
model facilitated the discussion of implementation by providing a
structure to scrutinise the clinical assumptions that underpinned
the results. The validity of these assumptions and objections
were debated at length within the ED clinician meeting. The
model acted as a reference point for this discussion (for example,
‘‘are those disability results real?’’ and ‘‘in your model you pre-
alert the ED, wouldn’t it be better to. . . ’’) and helped progress
to be made in reaching a final decision on implementation
within the ED, despite the objections of some staff members.
Outside of the group concerned about the clinical effectiveness
of thrombolysis, engaging the ED team in a collaborative manner
that was unusual to them with a model also helped with the
credibility of recommendations. Hence an additional proposition
for implementation theory may be the idea of a collaborative
forum for the mutual exchange of information and experiential
knowledge. If this can be developed within a modelling project
then the uptake and integration of different forms of knowledge
is increased.
In summary, our DES study was able to inform and support
a dramatic improvement in both the treatment rate for stroke
patients and the speed with which the treatment was delivered,
but the modelling process did not always work as expected. In
particular, we draw attention to the practical difficulties we faced
with gaining a representative understanding of ED’s view on the
problem and the use of VIS as an initial buy-in tool rather than a
device for continual engagement.
5.3. Limitations
While other studies of implementation have used qualitative
methods only (e.g. [8,50]), a particular strength of this evaluation
is the use of both the quantitative evaluation of system efficiency
and qualitative critique of the process that led to implementa-
tion. However, a weakness is that the qualitative study is based
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perspective which may be subject to some bias. A more system-
atic approach would incorporate an independent researcher to de-
velop and document the evaluation throughout. Such evaluations
might make use of systematic methods extracting group decision
development process data [51], frameworks for investigating im-
plementation processes such as the Promoting Action on Research
Implementation in Health Services (PARIHS) framework [52] and
sampling of process measures informed by the principles of Im-
provement Science [53].
Similarly we note that we framed the evaluation in terms of
the research team and the hospital and did not include users that
were not directly involved [54], i.e. services users: both carers and
patients. We found the tracking of disability measures post stroke
unfeasible for this project and even if theywere includedwewould
not gain an understanding of the perceived quality of care and
outcomes. A possible way to mitigate this in future studies may
be the involvement of service user representatives throughout a
simulation study and during implementation of its results [55].
6. Conclusions
Most published case studies of DES in health do not provide
any discussion of the implementation of study results [5] or any
structured evaluation. In order to provide an evidence base of
the impact of simulation modelling in practical applications it
is essential to publish accounts of implementation. One way to
build this evidence base is for case study authors to provide
an evaluation of implementation (or improved understanding) in
which the modelling process assisted, which may involve longer
timescales than anticipated. To contribute to this growing area,
this paper presents an evaluation of implementing the results of
a DES study of emergency stroke care. The results demonstrate
that the simulation did contribute to improvement, but change
was difficult and the intervention did not always match the
research team’s assumptions about how things would work. This
‘not matching’ has enabled the theories to be refined and added
to in a way that can inform future modelling practice and help
DES studies to better address the knowledge deficits that can have
such a negative impact on health outcomes. In order to minimise
interpretation bias and create generalisable knowledge to improve
simulation interventions, more systematic prospective evaluation
is needed; this is likely to include specialist knowledge different to
that of a typical expert in simulation.
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